International Clinical Trial: Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07736196) titled 'Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome' on July 25.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Assiut University

Condition: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI) Dual Anti-platelet Therapy

Intervention: Drug: Aspirin-Free Strategy

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: July 15, 2026

Target Sample Size: 300

Countries of Recruitment: Egypt...